Arcturus Therapeutics (United States)

Arcturus Therapeutics (United States)

Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Arcturus Therapeutics (United States), United States, covering academic research published from 2002 to 2023. Read More.


Open Access Percentage

63%


Total
Publications

120


Total Open
Publications

76


Total
Citations

6.2K


Open Access
Percentage

63%


Total
Publications

120


Total Open
Publications

76


Total
Citations

6.2K

Wikipedia

Website

download

Breakdown

12% 32% 20% 36%

Publisher Open

12%

Both

32%

Other Platform Open

20%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

17

Hybrid 23%

12

No Guarantees 44%

23

Other Platform Open

Domain 81%

50

Preprint 15%

9

Institution 13%

8

Other Internet 11%

7

Public 3%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
49
Europe PMC
Domain
38
bioRxiv
Preprint
4
DOI
Other Internet
3
Unknown Repository
Other Internet
2
Semantic Scholar
Public
2
Research Square
Preprint
2
medRxiv
Preprint
2
King's College London - Research Portal
Institution
2
Ghent University - Ghent University Academic Bibliography
Institution
2
1 / 3

Data updated 17 June 2024

Share

Share

Share